Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. | Viruses | 2021 | 35062245 | PubTator, text mining | PubMed |
| Targeting Epigenetic Mechanisms in Vascular Aging. | Front Cardiovasc Med | 2021 | 35059451 | PubTator, text mining | PubMed |
| MicroRNA-Enriched Exosomes from Different Sources of Mesenchymal Stem Cells Can Differentially Modulate Functions of Immune Cells and Neurogenesis. | Biomedicines | 2021 | 35052749 | PubTator, text mining | PubMed |
| Editorial Research Topic: Non-coding RNA as Therapeutic Target: A Game Changer in Cardiac Regenerative Strategies? | Front Physiol | 2021 | 35046842 | PubTator, text mining | PubMed |
| Relationship between mir-126 expression in children with psoriasis, disease progression and therapeutic response. | J Med Life | 2021 | 35027969 | PubTator, text mining | PubMed |
| [Differences in plasma miRNA levels in inferior petrosal sinus samples of patients with ACTH-dependent Cushing's syndrome]. | Probl Endokrinol (Mosk) | 2021 | 35018758 | PubTator, text mining | PubMed |
| New Promising Therapeutic Avenues of Curcumin in Brain Diseases. | Molecules | 2021 | 35011468 | PubTator, text mining | PubMed |
| The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential. | Molecules | 2021 | 35011442 | PubTator, text mining | PubMed |
| Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved. | Int J Mol Sci | 2021 | 35008715 | PubTator, text mining | PubMed |
| The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions. | Int J Mol Sci | 2021 | 35008540 | PubTator, text mining | PubMed |
| MiR-155: An Important Regulator of Neuroinflammation. | Int J Mol Sci | 2021 | 35008513 | PubTator, text mining | PubMed |
| Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway. | J Hepatocell Carcinoma | 2021 | 35004391 | PubTator, text mining | PubMed |
| MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα. | Anal Cell Pathol (Amst) | 2021 | 35004133 | PubTator, text mining | PubMed |
| Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis. | Front Immunol | 2021 | 35003111 | PubTator, text mining | PubMed |
| Advances With Non-coding RNAs in Neuropathic Pain. | Front Neurosci | 2021 | 35002601 | PubTator, text mining | PubMed |
| miRNA Combinatorics and its Role in Cell State Control-A Probabilistic Approach. | Front Mol Biosci | 2021 | 34993232 | PubTator, text mining | PubMed |
| The Role of Mesenchymal Stromal Cells-Derived Small Extracellular Vesicles in Diabetes and Its Chronic Complications. | Front Endocrinol (Lausanne) | 2021 | 34987478 | PubTator, text mining | PubMed |
| Oleanolic Acid Inhibits Neuronal Pyroptosis in Ischaemic Stroke by Inhibiting miR-186-5p Expression. | Exp Neurobiol | 2021 | 34983881 | PubTator, text mining | PubMed |
| microRNAs in cancer chemoresistance: The sword and the shield. | Noncoding RNA Res | 2021 | 34977437 | PubTator, text mining | PubMed |
| Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147. | Front Immunol | 2021 | 34975837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=64